Hormone therapy for diffuse mastopathy

Hormone therapy for diffuse mastopathy

The paper considers the issues of hormone therapy for diffuse fibrocystic mastopathy concurrent with different hormonal homeostatic disorders and gynecological diseases.

Bibliographic Details
Main Authors:	I. V. Vysotskaya, V. P. Letyagin, N. V. Levkina
Format:	Article
Language:	Russian
Published:	ABV-press 2014-11-01
Series:	Opuholi Ženskoj Reproduktivnoj Sistemy
Subjects:	breast cancer dyshormonal dysplasia hormone correction gestagens antiestrogens combined oral contraceptives gonadotropin- releasing hormone agonists
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/395

Similar Items

Possibilities of hormonal therapy for diffuse dyshormonal dysplasia of the breast
by: I. V. Vysotskaya
Published: (2014-07-01)

Practical guidelines for drug correction of diffuse dyshormonal dysplasia of the breast
by: I. V. Vysotskaya, et al.
Published: (2014-07-01)

DIFFERENTIAL APPROACH TO ADENOMYOSIS TREATMENT
by: I. S. Sidorova, et al.
Published: (2016-09-01)

OVERCOME BARRIERS IN PRESCRIPTION OF HORMONAL CONTRACEPTION (CLINICAL LECTURE)
by: O. A. Pustotina, et al.
Published: (2016-12-01)

PARTICULAR FEATURES OF OVARIAN CYSTS AND ENDOMETRIOSIS TREATMENT
by: I. S. Sidorova, et al.
Published: (2016-09-01)

Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty
by: Stefanie Schubert, et al.
Published: (2021-06-01)

A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
by: Jumpei Asakawa, et al.
Published: (2018-07-01)

Male contraception
by: Vivek Mathew, et al.
Published: (2012-01-01)

Problems in the treatment of dyshormonal breast hyperplasia: current aspects
by: E. A. Sukhareva, et al.
Published: (2014-08-01)

Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
by: Kuan-Hao Tsui, et al.
Published: (2014-03-01)

Effect of vaginal estriol use in total laparoscopic hysterectomy with gonadotropin-releasing hormone agonist therapy
by: Go Hirata, et al.
Published: (2018-01-01)

Comparison of gonadotropin-releasing hormone agonist with GnRH antagonist in polycystic ovary syndrome patients undergoing in vitro fertilization cycle: Retrospective analysis from a tertiary center and review of literature
by: Neeta Singh, et al.
Published: (2014-01-01)

A Case of Thromboembolism After Injection of Gonadotropin-releasing Hormone Agonist
by: Feng Zhou, et al.
Published: (2016-01-01)

Aggressive angiomyxoma of the vulva: dramatic response to gonadotropin-releasing hormone agonist therapy
by: Azar Danesh, et al.
Published: (2007-08-01)

Opportunities for ovarian reserve preservation in the treatment of oncological diseases
by: Juliia E. Dobrokhotova, et al.
Published: (2020-04-01)

Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist
by: Eun Jin Han, et al.
Published: (2013-09-01)

Use of a Gonadotropin-Releasing Hormone Agonist to Manage Perimenopausal Women With Symptomatic Uterine Myomas
by: Peng-Hui Wang, et al.
Published: (2009-06-01)

Vaginal Expulsion of a Submucosal Myoma During Treatment with Long-Acting Gonadotropin-Releasing Hormone Agonist
by: Lily Wen, et al.
Published: (2006-06-01)

Long-term follow-up of severely symptomatic women with adenomyoma treated with combination therapy
by: Wei-Min Liu, et al.
Published: (2013-03-01)

Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs
by: Maira Huerta-Reyes, et al.
Published: (2019-10-01)

Effect of luteal phase support gonadotropin-releasing hormone agonist on the endometrial receptivity and outcomes of in vitro fertilization programs
by: E M Savelyeva, et al.
Published: (2016-06-01)

Pharmacoeconomic study of the degarelix drug use for treatment of hormone-dependent prostate cancer compared to gonadotropin-releasing hormone analogs
by: A. G. Tolkushin, et al.
Published: (2018-04-01)

Gonadotropin-Releasing Hormone and Its Role in the Enteric Nervous System
by: Bodil Ohlsson, et al.
Published: (2017-06-01)

Effect of Endometrium Thickness on Clinical Outcomes in Luteal Phase Short-Acting GnRH-a Long Protocol and GnRH-Ant Protocol
by: Jie Zhang, et al.
Published: (2021-05-01)

The role of the GLU2.53(90) residue in gonadotropin-releasing hormone receptor expression and function
by: Manilall, Ashmeetha
Published: (2017)

Use of Buserelin depot, a gonadotropin-releasing hormone agonist, in the treatment of prostate cancer
by: L. M. Rapoport, et al.
Published: (2014-12-01)

Use of Buserelin depot, a gonadotropin-releasing hormone agonist, in the treatment of prostate cancer
by: L. M. Rapoport, et al.
Published: (2014-12-01)

Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty
by: Hye Ryun Kim, et al.
Published: (2017-12-01)

Uterine fibroids: an update on current and emerging medical treatment options
by: Farris M, et al.
Published: (2019-01-01)

Mastopathy Myths and Reality: Good Choice for Pharm Industry?
by: Gulbarshin Darisheva, et al.
Published: (2018-09-01)

ENDOMETRIOSIS AND FERTILITY. KEY MOMENT OF TREATMENT
by: S. A. Gasparyan, et al.
Published: (2016-06-01)

Gonadotropin-releasing hormone agonist combined with hormone replacement therapy does not improve the reproductive outcomes of frozen-thawed embryo transfer cycle in elderly patients: a retrospective study
by: Mei Dong, et al.
Published: (2020-07-01)

Comparative characteristics of hormonal profiles in autonomic-dyshormonal myocardial dystrophy of various ethiology
by: V. R. Mkrtchyan
Published: (2005-12-01)

Ovarian Cyst Formation Following Gonadotropin-Releasing Hormone-Agonist Administration Decreases the Oocyte Quality in IVF Cycles
by: Muammer Doğan, et al.
Published: (2012-06-01)

Short-term efficacy of 1-month and 3-month gonadotropin-releasing hormone agonist depots in girls with central precocious puberty
by: Min Jin Jeon, et al.
Published: (2021-09-01)

Personal selection of hormonal contraception
by: I V Kuznetsova
Published: (2017-08-01)

Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study
by: Nalini Mahajan, et al.
Published: (2016-01-01)

No significant long-term complications from inadvertent exposure to gonadotropin-releasing hormone agonist during early pregnancy in mothers and offspring: a retrospective analysis
by: Huan Wu, et al.
Published: (2021-03-01)

Expression of genes for Kisspeptin (KISS1), Neurokinin B (TAC3), Prodynorphin (PDYN), and gonadotropin inhibitory hormone (RFRP) across natural puberty in ewes
by: Qun Li, et al.
Published: (2020-03-01)

Effect of gonadotropin-releasing hormone agonist therapy on body mass index and growth in girls with idiopathic central precocious puberty
by: Ahmet Anik, et al.
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_n7hhhf5qf4hepqkc1hh7euj5ck